The Recall Desk
ModerateFDA (Devices)·Z-0524-2016·Announced 2015-12-30

Ameditech ProScreen 5 Panel Dip Card Recalled for Reduced Benzodiazepine Reactivity

Ameditech is recalling ProScreen 5 Panel Dip Cards because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class III, which is typically a score of 1 or 2. The hazard involves reduced reactivity for specific compounds, which is a performance issue rather than a direct physical injury risk, fitting the Moderate category for low-risk issues.

Plain-English summary

Ameditech Inc is recalling 120 kits of the ProScreen 5 Panel Dip Card w/Adult, Item No. PSDA-5MB300. The recall is due to reduced reactivity for up to two of the nineteen Benzodiazepine (BZO) compounds listed in the product insert.

The specific compounds affected by the reduced reactivity are Clonazepam and Chlordiazepoxide. The product was distributed nationwide.

Consumers should stop using the affected products and contact Ameditech Inc for further instructions.

The recalled product

Product
ProScreen 5 Panel Dip Card w/Adult, Item No. PSDA-5MB300
Manufacturer
Ameditech Inc
Affected units
120

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • 152912

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 59 recalled by Ameditech Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 59 products in this recall →